JG
BSX icon

Jefferies Group’s Boston Scientific BSX Stock Holding History

Jefferies Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.94M Hold
50,000
– – 0.02% 618
2022
Q2 		$1.86M Hold
50,000
– – 0.02% 633
2022
Q1 		$2.21M Sell
50,000
-72,400
-59% -$3.14M 0.01% 658
2021
Q4 		$5.2M Buy
+122,400
New +$5.14M 0.03% 443
2021
Q1 		– Sell
-7,000
Closed -$252K – 1644
2020
Q4 		$252K Hold
7,000
– – ﹤0.01% 1319
2020
Q3 		$267K Sell
7,000
-129,700
-95% -$5M ﹤0.01% 1122
2020
Q2 		$4.8K Buy
136,700
+63,100
+86% +$2.27M 0.06% 283
2020
Q1 		$2.4M Buy
73,600
+43,400
+144% +$1.7M 0.03% 605
2019
Q4 		$1.37M Sell
30,200
-49,600
-62% -$2.08M 0.01% 1277
2019
Q3 		$3.25M Buy
79,800
+67,900
+571% +$2.88M 0.03% 756
2019
Q2 		$511K Buy
+11,900
New +$458K ﹤0.01% 1655
2018
Q4 		– Sell
-50,000
Closed -$1.93M – 2173
2018
Q3 		$1.93M Sell
50,000
-120,200
-71% -$4.2M 0.01% 999
2018
Q2 		$5.57M Buy
+170,200
New +$5.13M 0.03% 477
2018
Q1 		– Sell
-400
Closed -$10K – 2268
2017
Q4 		$10K Sell
400
-89,500
-100% -$2.47M ﹤0.01% 2435
2017
Q3 		$2.62M Buy
89,900
+1,700
+2% +$46.9K 0.02% 811
2017
Q2 		$2.44M Sell
88,200
-117,900
-57% -$3.13M 0.02% 859
2017
Q1 		$5.13M Buy
206,100
+63,000
+44% +$1.53M 0.04% 495
2016
Q4 		$3.1M Buy
143,100
+49,600
+53% +$1.08M 0.02% 758
2016
Q3 		$2.23M Buy
+93,500
New +$2.23M 0.01% 879
2016
Q1 		– Sell
-200
Closed -$4K – 2217
2015
Q4 		$4K Buy
+200
New +$3.58K ﹤0.01% 2214
2015
Q3 		– Sell
-194,200
Closed -$3.44M – 2334
2015
Q2 		$3.44M Buy
+194,200
New +$3.47M 0.02% 670
2014
Q4 		– Sell
-37,000
Closed -$437K – 1963
2014
Q3 		$437K Sell
37,000
-203,000
-85% -$2.56M ﹤0.01% 1401
2014
Q2 		$3.06M Hold
240,000
– – 0.03% 493
2014
Q1 		$3.25M Buy
+240,000
New +$3.15M 0.03% 446

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Jefferies Group's BSX Position: Q3 2022 in Review

Jefferies Group reduced its Boston Scientific (BSX) stake by 9.4% in Q3 2022, selling an estimated $200K and leaving 47,911 shares worth $1.86M. The position accounts for 0.02% of the portfolio, ranked #635.

Jefferies Group first reported a position in BSX in Q2 2013 and has held it in 36 quarters since. The position peaked at $6.59M in Q4 2017. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

  • Jefferies Group held 47,911 shares of Boston Scientific worth $1.86M as of Q3 2022.
  • Jefferies Group sold 4,998 Boston Scientific shares in Q3 2022, an estimated $200K.
  • Boston Scientific made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #635 holding.
  • Jefferies Group first reported a position in Boston Scientific in Q2 2013 and has held it in 36 quarters since.
  • Jefferies Group's Boston Scientific position peaked at $6.59M in Q4 2017.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.